GHSI
Income statement / Annual
Last year (2023), Guardion Health Sciences, Inc.'s total revenue was $12.25 M,
an increase of 10.85% from the previous year.
In 2023, Guardion Health Sciences, Inc.'s net income was $158.03 K.
See Guardion Health Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$12.25 M |
$11.05 M |
$7.23 M |
$1.89 M |
$902.94 K |
$942.15 K |
$437.35 K |
$141.03 K |
$112.81 K |
$164.58 K |
| Cost of Revenue |
$6.85 M
|
$6.53 M
|
$4.12 M
|
$1.95 M
|
$341.32 K
|
$398.18 K
|
$175.47 K
|
$75.70 K
|
$50.07 K
|
$145.53 K
|
| Gross Profit |
$5.39 M
|
$4.52 M
|
$3.11 M
|
-$56.79 K
|
$561.62 K
|
$543.97 K
|
$261.88 K
|
$65.33 K
|
$62.74 K
|
$19.05 K
|
| Gross Profit Ratio |
0.44
|
0.41
|
0.43
|
-0.03
|
0.62
|
0.58
|
0.6
|
0.46
|
0.56
|
0.12
|
| Research and Development Expenses |
$150.68 K
|
$193.80 K
|
$64.36 K
|
$160.98 K
|
$194.31 K
|
$231.85 K
|
$259.46 K
|
$64.03 K
|
$401.91 K
|
$43.44 K
|
| General & Administrative Expenses |
$7.48 M
|
$9.58 M
|
$11.20 M
|
$6.83 M
|
$7.43 M
|
$4.93 M
|
$4.68 M
|
$3.31 M
|
$5.61 M
|
$638.00 K
|
| Selling & Marketing Expenses |
$1.70 M
|
$2.07 M
|
$2.32 M
|
$1.45 M
|
$1.87 M
|
$1.52 M
|
$599.93 K
|
$389.11 K
|
$180.13 K
|
$46.77 K
|
| Selling, General & Administrative Expenses |
$9.19 M
|
$11.65 M
|
$13.53 M
|
$8.28 M
|
$9.30 M
|
$6.46 M
|
$5.28 M
|
$3.70 M
|
$5.79 M
|
$684.77 K
|
| Other Expenses |
$394.55 K
|
$3.57 M
|
$10.14 M
|
$0.00
|
$1.22 M
|
$0.00
|
$0.00
|
$174.04 K
|
-$1.70 M
|
$0.00
|
| Operating Expenses |
$9.73 M
|
$11.84 M
|
$13.59 M
|
$8.45 M
|
$9.50 M
|
$6.69 M
|
$5.54 M
|
$3.76 M
|
$6.19 M
|
$728.21 K
|
| Cost And Expenses |
$16.58 M
|
$18.37 M
|
$17.72 M
|
$10.39 M
|
$9.84 M
|
$7.09 M
|
$5.72 M
|
$3.84 M
|
$6.24 M
|
$873.74 K
|
| Interest Income |
$379.52 K
|
$152.57 K
|
$1.80 K
|
$7.27 K
|
$258.37 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$611.34 K
|
| Interest Expense |
$0.00
|
$15.35 M
|
$0.00
|
$7.27 K
|
$258.37 K
|
$2.29 K
|
$23.73 K
|
$1.10 M
|
$752.95 K
|
$0.00
|
| Depreciation & Amortization |
$19.42 K
|
$1.25 M
|
$910.37 K
|
$219.60 K
|
$625.79 K
|
$295.67 K
|
$118.82 K
|
$60.13 K
|
$53.74 K
|
$43.23 K
|
| EBITDA |
-$3.92 M |
-$6.07 M |
-$9.70 M |
-$8.34 M |
-$9.99 M |
-$7.47 M |
-$5.16 M |
-$4.58 M |
-$8.03 M |
-$665.92 K |
| EBITDA Ratio |
-0.32
|
-0.55
|
-1.34
|
-4.42
|
-11.07
|
-7.93
|
-11.8
|
-32.5
|
-71.22
|
-4.05
|
| Operating Income Ratio |
-0.35
|
0.04
|
-1.45
|
-4.53
|
-9.89
|
-6.52
|
-12.08
|
-27.98
|
-56.63
|
-4.31
|
| Total Other Income/Expenses Net |
$4.49 M
|
$2.50 M
|
$1.80 K
|
-$19.93 K
|
-$381.37 K
|
-$1.62 M
|
-$23.73 K
|
-$1.80 M
|
-$2.45 M
|
-$611.34 K
|
| Income Before Tax |
$158.03 K
|
-$14.92 M
|
-$24.75 M
|
-$8.57 M
|
-$10.88 M
|
-$7.77 M
|
-$5.31 M
|
-$5.75 M
|
-$8.84 M
|
-$1.32 M
|
| Income Before Tax Ratio |
0.01
|
-1.35
|
-3.42
|
-4.54
|
-12.05
|
-8.24
|
-12.13
|
-40.76
|
-78.37
|
-8.02
|
| Income Tax Expense |
$0.00
|
$15.35 M
|
$672.79 K
|
$7.27 K
|
$258.37 K
|
-$1.62 M
|
$0.00
|
$1.10 M
|
-$946.66 K
|
$0.00
|
| Net Income |
$158.03 K
|
-$30.28 M
|
-$24.75 M
|
-$8.58 M
|
-$11.14 M
|
-$7.77 M
|
-$5.31 M
|
-$5.75 M
|
-$8.84 M
|
-$1.32 M
|
| Net Income Ratio |
0.01
|
-2.74
|
-3.42
|
-4.54
|
-12.33
|
-8.24
|
-12.13
|
-40.76
|
-78.37
|
-8.02
|
| EPS |
0.12 |
-27.01 |
-52.23 |
-180.53 |
-91.61 |
-105.39 |
-72.6 |
-78.66 |
-120.98 |
-73.21 |
| EPS Diluted |
0.12 |
-27.01 |
-52.23 |
-180.53 |
-91.61 |
-105.09 |
-72.6 |
-78.66 |
-120.98 |
-73.21 |
| Weighted Average Shares Out |
$1.27 M
|
$1.12 M
|
$473.77 K
|
$47.52 K
|
$121.56 K
|
$73.70 K
|
$73.08 K
|
$73.08 K
|
$73.08 K
|
$18.04 K
|
| Weighted Average Shares Out Diluted |
$1.27 M
|
$1.12 M
|
$473.77 K
|
$47.52 K
|
$121.56 K
|
$73.91 K
|
$73.08 K
|
$73.08 K
|
$73.08 K
|
$18.04 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
